Compare · DSGR vs STE
DSGR vs STE
Side-by-side comparison of Distribution Solutions Group Inc. (DSGR) and STERIS plc (Ireland) (STE): market cap, price performance, sector, and recent activity on the wire.
Summary
- DSGR operates in Consumer Discretionary, while STE operates in Health Care - the two are in different parts of the market.
- STE is the larger of the two at $23.05B, about 14.3x DSGR ($1.61B).
- STE has been more active in the news (16 items in the past 4 weeks vs 4 for DSGR).
- STE has more recent analyst coverage (17 ratings vs 1 for DSGR).
- Company
- Distribution Solutions Group Inc.
- STERIS plc (Ireland)
- Price
- -
- -
- Market cap
- $1.61B
- $23.05B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 4
- 16
- Recent ratings
- 1
- 17
STERIS plc (Ireland)
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. This segment offers its products and services to acute care hospitals and other healthcare settings. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The company is based in Dublin, Ireland.
Latest DSGR
- TE Chief Executive Officer Litwin Barry was granted 17,500 units of Restricted Stock Units and returned $216,464 worth of Restricted Stock Units to the company (6,190 units at $34.97), increasing direct ownership by 101% to 22,502 units (SEC Form 4)
- SEC Form 10-Q filed by Distribution Solutions Group Inc.
- Distribution Solutions Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Distribution Solutions Group Announces 2026 Second Quarter Results
- Distribution Solutions Group Announces Timing for Second Quarter Fiscal Year 2026 Results
- Amendment: SEC Form SCHEDULE 13D/A filed by Distribution Solutions Group Inc.
- SEC Form DEFA14A filed by Distribution Solutions Group Inc.
- Distribution Solutions Group Inc. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Entry into a Material Definitive Agreement, Regulation FD Disclosure
- TestEquity Expands Environmental Chamber Sales Reach with Millennium Alliance Representation Across the Midwest
- Distribution Solutions Group to Be Taken Private by Affiliates of LKCM Headwater Investments for $35.00 Per Common Share in Cash
Latest STE
- SEC Form 144 filed by STERIS plc (Ireland)
- SEC Form 4 filed by Director Shapiro Louis
- Director Sohi Mohsen exercised 4,058 units of Ordinary Shares at a strike of $86.23 and sold $956,795 worth of Ordinary Shares (4,058 units at $235.78) (SEC Form 4)
- SEC Form 4 filed by Director Shah Nirav R
- SEC Form 4 filed by Director Martin Paul Edward
- SEC Form 4 filed by Director Boulud Pierre
- SEC Form 4 filed by Director Feldmann Cynthia L
- SEC Form 4 filed by Director Holland Christopher S
- SEC Form 4 filed by Director Alegria Esther M.
- SEC Form 144 filed by STERIS plc (Ireland)